𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to increasing doses of octreotide in a patient with carcinoid syndrome

✍ Scribed by Ajani, Jaffer A.; Chesnut, Jennifer R.

Book ID
123088023
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
271 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of carcinoid syndrome : A pros
Treatment of carcinoid syndrome : A prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance
✍ Dermot O'Toole; Michel Ducreux; Gilles Bommelaer; Jean-Louis Wemeau; Olivier Bou πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 78 KB

## BACKGROUND. The somatostatin analogues lanreotide and octreotide have previously been shown to be effective in controlling flushing and diarrhea in patients with carcinoid syndrome. As lanreotide requires injection only every 10 days, compared with twice-daily injections of octreotide, a direct